{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T14:55:25Z","timestamp":1773413725910,"version":"3.50.1"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This case of HIV-1-seronegative infection due to very early treatment demonstrates that even in the absence of sufficient HIV replication to generate detectable immunity, a competent reservoir can accumulate, allowing replication to resume despite 20 months of effective treatment and the disappearance of molecular evidence of infection.<\/jats:p>","DOI":"10.1093\/cid\/ciaf422","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:51:24Z","timestamp":1753876284000},"page":"262-264","source":"Crossref","is-referenced-by-count":0,"title":["Consequences of Stopping Antiretroviral Treatment in a Persistently Seronegative Individual with HIV-1"],"prefix":"10.1093","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3723-4142","authenticated-orcid":false,"given":"Marc","family":"Wirden","sequence":"first","affiliation":[{"name":"INSERM, Institut Pierre Louis d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique, (IPLESP), Sorbonne Universit\u00e9 , Paris ,","place":["France"]},{"name":"Service de Virologie, AP-HP, H\u00f4pital Piti\u00e9 Salp\u00eatri\u00e8re , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelie","family":"Guihot","sequence":"additional","affiliation":[{"name":"Centre d\u2019Immunologie et des Maladies Infectieuses (CIMI-Paris), Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1135, CNRS ERL8255, Sorbonne Universit\u00e9 , Paris ,","place":["France"]},{"name":"Service d\u2019Immunologie, AP-HP, H\u00f4pital Piti\u00e9 Salp\u00eatri\u00e8re , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Gautheret-Dejean","sequence":"additional","affiliation":[{"name":"Service de Virologie, AP-HP, H\u00f4pital Piti\u00e9 Salp\u00eatri\u00e8re , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5993-687X","authenticated-orcid":false,"given":"Delphine","family":"Sterlin","sequence":"additional","affiliation":[{"name":"Centre d\u2019Immunologie et des Maladies Infectieuses (CIMI-Paris), Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1135, CNRS ERL8255, Sorbonne Universit\u00e9 , Paris ,","place":["France"]},{"name":"Service d\u2019Immunologie, AP-HP, H\u00f4pital Piti\u00e9 Salp\u00eatri\u00e8re , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Fay\u00e7al","sequence":"additional","affiliation":[{"name":"INSERM, Institut Pierre Louis d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique, (IPLESP), Sorbonne Universit\u00e9 , Paris ,","place":["France"]},{"name":"Service des Maladies Infectieuses, AP-HP, H\u00f4pital Piti\u00e9 Salp\u00eatri\u00e8re , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theophile","family":"Cocherie","sequence":"additional","affiliation":[{"name":"INSERM, Institut Pierre Louis d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique, (IPLESP), Sorbonne Universit\u00e9 , Paris ,","place":["France"]},{"name":"Service de Virologie, AP-HP, H\u00f4pital Piti\u00e9 Salp\u00eatri\u00e8re , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Calvez","sequence":"additional","affiliation":[{"name":"INSERM, Institut Pierre Louis d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique, (IPLESP), Sorbonne Universit\u00e9 , Paris ,","place":["France"]},{"name":"Service de Virologie, AP-HP, H\u00f4pital Piti\u00e9 Salp\u00eatri\u00e8re , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Genevieve","family":"Marcelin","sequence":"additional","affiliation":[{"name":"INSERM, Institut Pierre Louis d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique, (IPLESP), Sorbonne Universit\u00e9 , Paris ,","place":["France"]},{"name":"Service de Virologie, AP-HP, H\u00f4pital Piti\u00e9 Salp\u00eatri\u00e8re , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Tubiana","sequence":"additional","affiliation":[{"name":"INSERM, Institut Pierre Louis d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique, (IPLESP), Sorbonne Universit\u00e9 , Paris ,","place":["France"]},{"name":"Service des Maladies Infectieuses, AP-HP, H\u00f4pital Piti\u00e9 Salp\u00eatri\u00e8re , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"2026031306470504000_ciaf422-B1","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/cid\/ciw369","article-title":"Editorial commentary: timing is everything: shortcomings of current HIV diagnostics in the early treatment era","volume":"63","author":"Keating","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2026031306470504000_ciaf422-B2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/cid\/ciw365","article-title":"Initiation of antiretroviral therapy during acute HIV-1 infection leads to a high rate of nonreactive HIV serology","volume":"63","author":"de Souza","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2026031306470504000_ciaf422-B3","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/infdis\/jiy120","article-title":"Nonreactive human immunodeficiency virus type 1 rapid tests after sustained viral suppression following antiretroviral therapy initiation during primary infection","volume":"217","author":"Stefic","year":"2018","journal-title":"J Infect Dis"},{"key":"2026031306470504000_ciaf422-B4","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/jmv.24874","article-title":"Interlaboratory quality control of total HIV-1 DNA load measurement for multicenter reservoir studies","volume":"89","author":"Gantner","year":"2017","journal-title":"J Med Virol"},{"key":"2026031306470504000_ciaf422-B5","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/QAD.0b013e32833ac65c","article-title":"Seronegative HIV-1 infection: a review of the literature","volume":"24","author":"Spivak","year":"2010","journal-title":"AIDS"},{"key":"2026031306470504000_ciaf422-B6","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1086\/428127","article-title":"Incomplete HIV type 1 antibody evolution and seroreversion in acutely infected individuals treated with early antiretroviral therapy","volume":"40","author":"Kassutto","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2026031306470504000_ciaf422-B7","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/500215","article-title":"Seroreversion in subjects receiving antiretroviral therapy during acute\/early HIV infection","volume":"42","author":"Hare","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2026031306470504000_ciaf422-B8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-6405-3-22","article-title":"Partial protective effect of CCR5-Delta 32 heterozygosity in a cohort of heterosexual Italian HIV-1 exposed uninfected individuals","volume":"3","author":"Trecarichi","year":"2006","journal-title":"AIDS Res Ther"},{"key":"2026031306470504000_ciaf422-B9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.virol.2008.06.036","article-title":"Impact of Delta 32-CCR5 heterozygosity on HIV-1 genetic evolution and variability\u2014a study of 4 individuals infected with closely related HIV-1 strains","volume":"379","author":"Chalmet","year":"2008","journal-title":"Virology"},{"key":"2026031306470504000_ciaf422-B10","doi-asserted-by":"crossref","first-page":"107222","DOI":"10.1016\/j.ijid.2024.107222","article-title":"Suppressed HIV antibody responses following exposure to antiretrovirals\u2014evidence from PrEP randomized trials and early antiretroviral treatment initiation studies","volume":"148","author":"Avelino-Silva","year":"2024","journal-title":"Int J Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaf422\/63901250\/ciaf422.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/2\/262\/63901250\/ciaf422.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/2\/262\/63901250\/ciaf422.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T10:47:10Z","timestamp":1773398830000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/82\/2\/262\/8220010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":10,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,7,31]]},"published-print":{"date-parts":[[2026,2,25]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf422","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2,15]]},"published":{"date-parts":[[2025,7,31]]}}}